Literature DB >> 33708054

Desmoid Type Fibromatosis of the Breast: Ten-Year Institutional Results of Imaging, Histopathology, and Surgery.

Jörn Lorenzen1, Miriam Cramer1, Nina Buck1, Kay Friedrichs2, Kirsten Graubner3, Clara Sonja Lühr4, Christoph Lindner3, Axel Niendorf4.   

Abstract

BACKGROUND: Desmoid type fibromatoses has proven to be a diagnostic and therapeutic challenge, as they often appear primarily as a carcinoma of the breast with a high recurrence risk. PATIENTS: A digital archive search was performed for the period from 2009 to the end of 2018. Inclusion criteria consisted of histological examination of at least the surgical specimen in the reference pathology department and at least a second opinion diagnosis in the reference radiology department.
RESULTS: A total of 14 women and 1 man underwent surgery on desmoid type fibromatosis of the breast. The average patient age was 49 years (range: 22-72 years). The mean tumor size was 2.2 cm (range: 0.8-4.2 cm). The tumor was detectable in mammography in 12 out of 13 patients and in all 15 patients in sonography. MRI was performed preoperatively in 6 patients; in all of the patients, the tumor was visualized with inhomogeneous contrast enhancement. In the imaging procedures, all desmoid type fibromatoses were classified as suspicious. Performing the core biopsy, preoperative histology confirmed desmoid fibromatosis in 12 out of 15 patients. Nuclear stain for ß-catenin was positive in 7 out of 10 patients. Negative staining was found for AE1/A3 in 10 out of 10 and CD34 in 12 out of 12 patients. In all of the patients, a single-stage operation without the detection of border-forming tumor margins was performed. The follow-up interval ranged from 16 to 96 months (mean: 44.86 months, median: 43 months). In this follow-up period, no patient was diagnosed with desmoid tumor recurrence.
CONCLUSION: In imaging, desmoid type fibromatosis of the breast has typical malignancy-related criteria. Extensive preoperative diagnostics enable the planning of complete primary excision of the lesion and reduce the recurrence risk.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Desmoid type fibromatosis; Follow-up; Imaging; Immunohistochemistry; Recurrence; Resection margins

Year:  2020        PMID: 33708054      PMCID: PMC7923936          DOI: 10.1159/000507842

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  42 in total

Review 1.  Linking colorectal cancer to Wnt signaling.

Authors:  M Bienz; H Clevers
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosis.

Authors:  M L Janssen; D L M van Broekhoven; J M M Cates; W M Bramer; J J Nuyttens; A Gronchi; S Salas; S Bonvalot; D J Grünhagen; C Verhoef
Journal:  Br J Surg       Date:  2017-03       Impact factor: 6.939

3.  Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.

Authors:  Aimee M Crago; Juliann Chmielecki; Mara Rosenberg; Rachael O'Connor; Caitlin Byrne; Fatima G Wilder; Katherine Thorn; Phaedra Agius; Deborah Kuk; Nicholas D Socci; Li-Xuan Qin; Matthew Meyerson; Meera Hameed; Samuel Singer
Journal:  Genes Chromosomes Cancer       Date:  2015-07-14       Impact factor: 5.006

Review 4.  Extra-abdominal desmoid fibromatosis: A review of management, current guidance and unanswered questions.

Authors:  N Eastley; T McCulloch; C Esler; I Hennig; J Fairbairn; A Gronchi; R Ashford
Journal:  Eur J Surg Oncol       Date:  2016-02-19       Impact factor: 4.424

5.  β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.

Authors:  Magali Lacroix-Triki; Felipe C Geyer; Maryou B Lambros; Kay Savage; Ian O Ellis; Andrew H S Lee; Jorge S Reis-Filho
Journal:  Mod Pathol       Date:  2010-08-06       Impact factor: 7.842

6.  Fibromatosis of the breast.

Authors:  F E Gump; M J Sternschein; M Wolff
Journal:  Surg Gynecol Obstet       Date:  1981-07

Review 7.  An approach to the diagnosis of spindle cell lesions of the breast.

Authors:  Emad A Rakha; Mohammed A Aleskandarany; Andrew H S Lee; Ian O Ellis
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

Review 8.  Spindle cell lesions of the breast--the pathologic differential diagnosis.

Authors:  Gary M K Tse; Puay Hoon Tan; Philip C W Lui; Thomas C Putti
Journal:  Breast Cancer Res Treat       Date:  2007-07-18       Impact factor: 4.872

Review 9.  Desmoid Tumor and Silicone Breast Implant Surgery: Is There Really a Connection? A Literature Review.

Authors:  R Tzur; E Silberstein; Y Krieger; Y Shoham; Y Rafaeli; A Bogdanov-Berezovsky
Journal:  Aesthetic Plast Surg       Date:  2017-08-25       Impact factor: 2.326

Review 10.  An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG).

Authors:  B Kasper; C Baumgarten; J Garcia; S Bonvalot; R Haas; F Haller; P Hohenberger; N Penel; C Messiou; W T van der Graaf; A Gronchi
Journal:  Ann Oncol       Date:  2017-10-01       Impact factor: 32.976

View more
  3 in total

1.  Large Desmoid Tumor in the Setting of Prior Cosmetic Breast Augmentation.

Authors:  Kristin Krupa; Tianshen Hu; Ann R Mootz; Sumeet S Teotia; Rachel Wooldridge
Journal:  Eur J Breast Health       Date:  2022-10-01

2.  Imaging findings of a biopsy-proven desmoid tumor of the axilla in a young female.

Authors:  Farah Guirguis Mekhail; Justin R Montgomery; Paul J Spicer
Journal:  Radiol Case Rep       Date:  2022-02-03

3.  Fibromatosis of the breast in a male patient.

Authors:  Ting-Chang Sheu; Samantha C Phung; Denise M Mammolito; Jessica A Guingrich
Journal:  Radiol Case Rep       Date:  2022-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.